The Consideration of Cyclosporine in the Treatment of Stevens-Johnson Syndrome

JAMA Dermatol. 2024 Jan 1;160(1):117. doi: 10.1001/jamadermatol.2023.4767.
No abstract available

MeSH terms

  • Cyclosporine* / therapeutic use
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Stevens-Johnson Syndrome* / drug therapy
  • Stevens-Johnson Syndrome* / etiology

Substances

  • Cyclosporine
  • Immunosuppressive Agents